Grifols SA (ADR) - Level III Live Stock Price Today, Share Analysis and Chart

Name: Grifols SA - ADR - Level III: Is Infosys Ltd. worth buying?
Item: Grifols SA - ADR - Level III
Rating: 1.901013875
Author: Trendlyne DVM scores

Risky Value

about

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products d...

7.39 0.02 (0.27%)

New 52W Low in past week

415.1K

XNAS Volume

XNAS 26 Jun, 2026 5:30 PM (EDT)

Dividend

Grifols SA (ADR) - Level III has an upcoming dividend of $0.094 per share due on 02 Jul 2026 See details

Low Financial Strength

22.2 / 100

Affordable Valuation

68.2 / 100

Technically Neutral

39.5 / 100

Risky Value These stocks have weak financials and average momentum. They may be affordable, but investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 47%

2 analysts

Grifols SA (ADR) - Level III Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..